Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 28;41(4):417–426. doi: 10.1097/ICO.0000000000002837

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

FIGURE 3. — TearCare (BLACK, solid) achieved significantly greater proportion (P < 0.05) of patient experiencing OSDI improvement of at least one severity category and greater decrease in total lubricant drops use (P < 0.01) compared with LipiFlow (GRAY, dashed). Panel A, The proportion of subjects with OSDI severity category improvement was 72% for TearCare and 59% for the LipiFlow treatment group. Panel B, TearCare enabled a greater decrease in subject mean total lubricant drop usage compared with LipiFlow (22.93 ± 37.75 for the TearCare group and 27.9 ± −52.02 for the LipiFlow group). Error bars represent standard deviation.